Clinical case: prostatectomy for metastatic prostate cancer (observation 6 years in the poor prognosis group)
https://doi.org/10.17650/1726-9776-2017-13-1-139-146
Abstract
A description of a clinical case of a complex treatment and monitoring of patient with prostate cancer at a very unfavorable initial forecast, the presence of bone metastases with a good clinical outcome.
About the Author
V. I. Shirokorad
Moscow City Cancer Hospital No 62, Moscow Healthcare Department
Russian Federation
27 Istra Settlement, Moscow Region 143423
Competing Interests: Клинческий случай
Russian Federation
27 Istra Settlement, Moscow Region 143423
Competing Interests: Клинческий случай
References
1. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2014 году. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2015. C. 25–27, 31, 130–133. [Kaprin A.D., Starinskiy V.V., Petrova G.V. Malignant tumors in Russia in 2014. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2015. Pp. 25–27, 31, 130– 133. (In Russ.)].
2. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2015 году. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2016. 236 с. [Kaprin A.D., Starinskiy V.V., Petrova G.V. State of oncological care in Russia in 2015. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2016. 236 p. (In Russ.)].
3. Joniau S., Hsu C.Y., Lerut E. et al. A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer. Eur Urol 2007;51(2):388–94. DOI: 10.1016/j.eururo.2006.06.051. PMID: 16901622.
4. Van Poppel H., Joniau S. An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer. Eur Urol 2008;53(2):253–9. DOI: 10.1016/j.eururo.2007.10.009. PMID: 17949893. URL: http://www.ncbi.nlm.nih.gov/pubmed/17949893.
5. Faie I., Singer E.A., Pumill C. Kim I.Y. Cytoreductive prostatectomy: evidence in supportof a new surgical paradigm (Review). Int J Oncol 2014;45(6):2193–8. DOI: 10.3892/ijo.2014.2656. PMID: 25340386.
6. Heidenreich A., Ohlmann C., Ozgür E., Engelmann U. Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy. Urologe A 2006;45(4):474–81. DOI:10.1007/s00120-006-0995-9 PMID: 16465521.
7. Ristau B.T., Cahn D., Uzzo R.G. et al. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer. Future Oncol 2016;12(5):687–99. DOI: 10.2217/fon.15.355. PMID: 26839141.
8. Bryan R., Kirby R., Mostafid H. Role of radical prostatectomy in metastatic prostate cancer: data from the munich cancer registry. Int J Oncol 2014;45:2193–8.
9. Gautam G. Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer? Indian J Urol 2014;30(4):366–7. DOI: 10.4103/0970-1591.139593. PMID: 25378813.
10. Vallett B.S. Radical perineal prostatectomy subsequent to bilateral orchiectomy. Delaware Med J 1944;16:19–20.
11. McLeod D.G., Iversen P., See W.A. et al. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJU Int 2006;97(2):247–54. URL: http://www.ncbi.nlm.nih.gov/pubmed/16430622. DOI: 10.1111/j.1464-410X.2005.06051.x. PMID: 16430622.
12. Messing E.M., Manola J., Yao J. et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006;7(6):472–9. DOI: 10.1016/S1470-2045(06)70700-8. PMID:16750497. URL: http://www.ncbi.nlm.nih.gov/pubmed/16750497.
Review
For citations:
Shirokorad V.I. Clinical case: prostatectomy for metastatic prostate cancer (observation 6 years in the poor prognosis group). Cancer Urology. 2017;13(1):139-146. (In Russ.) https://doi.org/10.17650/1726-9776-2017-13-1-139-146
Views:
2695
Email this article 